Literature DB >> 9164767

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

R T Chen1, J W Glasser, P H Rhodes, R L Davis, W E Barlow, R S Thompson, J P Mullooly, S B Black, H R Shinefield, C M Vadheim, S M Marcy, J I Ward, R P Wise, S G Wassilak, S C Hadler.   

Abstract

OBJECTIVE: To fill the large "gaps and limitations" in current scientific knowledge of rare vaccine adverse events identified in recent reviews of the Institute of Medicine.
METHODS: Computerized information on immunization, medical outcomes, and potential confounders on more than 500 000 children 0 to 6 years of age is linked annually at several health maintenance organizations to create a large cohort for multiple epidemiologic studies of vaccine safety.
RESULTS: Analysis of 3 years of follow-up data shows that 549 488 doses of diphtheria-tetanus-pertussis (DTP) and 310 618 doses of measles-mumps-rubella (MMR) vaccines have been administered to children in the study cohort. Analyses for associations between vaccines and 34 medical outcomes are underway. Screening of automated data shows that seizures are associated with receipt of DTP on the same day (relative risk [RR], 2.1; 95% confidence interval [CI], 1.1 to 4.0) and 8 to 14 days after receipt of MMR (RR, 3.0; 95% CI, 2.1 to 4.2). The diversity of vaccination exposures in this large cohort permits us to show that an apparent association of seizures 8 to 14 days after Haemophilus influenzae type b vaccine (RR, 1.6; 95% CI, 1.2 to 2.1) was attributable to confounding by simultaneous MMR vaccination; the association disappears with appropriate adjustment (RR, 1.0; 95% CI, 0.7 to 1.4).
CONCLUSION: Preliminary design, data collection, and analytic capability of the Vaccine Safety Datalink project has been validated by replication of previous known associations between seizures and DTP and MMR vaccines. The diversity in vaccine administration schedules permits potential disentangling of effects of simultaneous and combined vaccinations. The project provides a model of public health-managed care collaborations in addition to an excellent infrastructure for safety and other studies of vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164767     DOI: 10.1542/peds.99.6.765

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  63 in total

1.  How organized medical care can advance public health.

Authors:  A Robbins; P Freeman
Journal:  Public Health Rep       Date:  1999 Mar-Apr       Impact factor: 2.792

Review 2.  Allergenic components of vaccines and avoidance of vaccination-related adverse events.

Authors:  J W Georgitis; M B Fasano
Journal:  Curr Allergy Rep       Date:  2001-01

3.  Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.

Authors:  Daniel A Salmon; Lawrence H Moulton; Neal A Halsey
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

4.  Evaluating the safety of new vaccines: summary of a workshop.

Authors:  Susan S Ellenberg; Mary A Foulkes; Karen Midthun; Karen L Goldenthal
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

5.  Partnerships in translation: advancing research and clinical care. The 14th Annual HMO Research Network Conference, April 13-16, 2008, Minneapolis, Minnesota.

Authors:  Robert T Greenlee; Laura A Coleman; Andrew F Nelson; Joseph V Selby
Journal:  Clin Med Res       Date:  2008-12

6.  Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Authors:  Christian Hoppe; Patrick Obermeier; Susann Muehlhans; Maren Alchikh; Lea Seeber; Franziska Tief; Katharina Karsch; Xi Chen; Sindy Boettcher; Sabine Diedrich; Tim Conrad; Bron Kisler; Barbara Rath
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

7.  An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.

Authors:  Kumanan Wilson; Katherine M Atkinson; Jacqueline Westeinde; Cameron Bell; Kim Marty; Dean Fergusson; Shelley L Deeks; Natasha Crowcroft; Julie A Bettinger
Journal:  Hum Vaccin Immunother       Date:  2016-02-23       Impact factor: 3.452

8.  A Ten-Year Case-Control Study of Passive Smoke Exposure as a Risk Factor for Pertussis in Children.

Authors:  Mark A Schmidt; Samantha K Kurosky; John P Mullooly; Colleen Chun; Sheila Weinmann
Journal:  Perm J       Date:  2015

Review 9.  Overview of issues in improving quality of care for children.

Authors:  E A McGlynn; N Halfon
Journal:  Health Serv Res       Date:  1998-10       Impact factor: 3.402

10.  Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Edward A Belongia; Simon J Hambidge; Jennifer Nelson; Roger Baxter; Allison Naleway; Charlene Gay; James Nordin; James Baggs; John Iskander
Journal:  BMC Infect Dis       Date:  2009-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.